Ignite Creation Date:
2024-05-05 @ 10:17 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000271
Status:
COMPLETED
Last Update Posted:
2017-07-05
First Post:
1999-09-20
Brief Title:
New Approaches to Cocaine Abuse Medications A - 6
Sponsor:
New York State Psychiatric Institute
Organization:
New York State Psychiatric Institute
Study Overview
Official Title:
New Approaches to Cocaine Abuse Medications A
Status:
COMPLETED
Status Verified Date:
2017-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to measure the effect of desipramine in cocaine abusers selected for major depression or dysthymia
Detailed Description:
This is a randomized 12-week double-blind placebo-controlled trial of outpatients meeting DSM-III-R criteria for cocaine dependence and major depression or dysthymia by SCID interview Participants were treated with desipramine up to 300 mg per day or matching placebo All patients received weekly individual manual-guided relapse prevention therapy Weekly outcome measures included the Clinical Global Impression Scale self-reported cocaine use and craving urine toxicology and the Hamilton Depression Scale
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 5P50DA009236-18 | NIH | None | httpsreporternihgovquickSearch5P50DA009236-18 |